×
Apr 17, 2023 · We report interim analysis results from the RATIONALE-306 study, which aimed to assess tislelizumab plus chemotherapy versus placebo plus ...
Missing: sca_esv= 544798f1b50553ec
People also ask
Oct 6, 2020 · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 8 Department of Clinical Haematology, Barwon Health, ...
Missing: sca_esv= 544798f1b50553ec
This study demonstrated that patients with early-stage Hodgkin's disease experience a short-term decrease in QOL and an increase in symptoms and fatigue ...
Missing: sca_esv= 544798f1b50553ec
There is a well-described association between childhood epilepsy and pervasive cognitive and behavioral deficits. Often these children not only have ictal ...
Missing: sca_esv= 544798f1b50553ec
Background: Atorvastatin is very effective in reducing plasma low-density lipoprotein cholesterol (LDL-C) levels. However, there is no long-term survival study ...
Missing: sca_esv= 544798f1b50553ec
The study regimen consisting of 2 cycles of neoadjuvant therapy was completed without a clinically significant QOL deterioration. A transient increase in ...
Missing: sca_esv= 544798f1b50553ec
Purpose: This study was designed to evaluate neoadjuvant intensified chemotherapy in potentially resectable or unresectable liver metastases (LM) from ...
Missing: sca_esv= 544798f1b50553ec
This tool uses predefined filters to help you quickly refine PubMed searches on clinical or disease-specific topics. To use this tool, enter your search terms ...
Missing: sca_esv= 544798f1b50553ec
In order to show you the most relevant results, we have omitted some entries very similar to the 8 already displayed. If you like, you can repeat the search with the omitted results included.